Literature DB >> 21242479

Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction.

Daniela Fraccarollo1, Stefan Berger, Paolo Galuppo, Susanne Kneitz, Lutz Hein, Günther Schütz, Stefan Frantz, Georg Ertl, Johann Bauersachs.   

Abstract

BACKGROUND: Mineralocorticoid receptor (MR) blockade improves morbidity and mortality among patients with heart failure; however, the underlying mechanisms are still under investigation. We studied left ventricular remodeling after myocardial infarction in mice with cardiomyocyte-specific inactivation of the MR gene (MR(MLCCre)) that were generated with a conditional MR allele (MR(flox)) in combination with a transgene expressing Cre recombinase under control of the myosin light-chain (MLC2a) gene promoter. METHODS AND
RESULTS: Control (MR(flox/flox), MR(flox/wt)) and MR(MLCCre) mice underwent coronary artery ligation. MR ablation had no detectable baseline effect on cardiac morphology and function. The progressive left ventricular chamber enlargement and functional deterioration in infarcted control mice, detected by echocardiography and conductance catheter analysis during the 8-week observation period, were substantially attenuated in MR(MLCCre) mice. Chronically infarcted MR(MLCCre) mice displayed attenuated pulmonary edema, reduced cardiac hypertrophy, increased capillary density, and reduced accumulation of extracellular matrix proteins in the surviving left ventricular myocardium. Moreover, cardiomyocyte-specific MR ablation prevented the increases in myocardial and mitochondrial O(2)(·-) production and upregulation of the NADPH oxidase subunits Nox2 and Nox4. At 7 days, MR(MLCCre) mice exhibited enhanced infarct neovessel formation and collagen structural organization associated with reduced infarct expansion. Mechanistically, cardiomyocytes lacking MR displayed accelerated stress-induced activation and subsequent suppression of nuclear factor-κB and reduced apoptosis early after myocardial infarction.
CONCLUSION: Cardiomyocyte-specific MR deficiency improved infarct healing and prevented progressive adverse cardiac remodeling, contractile dysfunction, and molecular alterations in ischemic heart failure, highlighting the importance of cardiomyocyte MR for heart failure development and progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21242479     DOI: 10.1161/CIRCULATIONAHA.110.983023

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  64 in total

Review 1.  30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The role of the mineralocorticoid receptor in the vasculature.

Authors:  Jennifer J DuPont; Iris Z Jaffe
Journal:  J Endocrinol       Date:  2017-07       Impact factor: 4.286

Review 2.  Cardiac myocyte-fibroblast interactions and the coronary vasculature.

Authors:  Stephanie L K Bowers; Troy A Baudino
Journal:  J Cardiovasc Transl Res       Date:  2012-09-18       Impact factor: 4.132

3.  Antioxidant and pro-oxidant mechanisms of (+) catechin in microsomal CYP2E1-dependent oxidative stress.

Authors:  Andres A Caro; Alanna Davis; Sydney Fobare; Nicholas Horan; Cameron Ryan; Cara Schwab
Journal:  Toxicol In Vitro       Date:  2018-09-06       Impact factor: 3.500

Review 4.  Mechanisms and Drug Development in Atrial Fibrillation.

Authors:  David Calvo; David Filgueiras-Rama; José Jalife
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 5.  Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease.

Authors:  Miki Nagase; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2013-01-08       Impact factor: 28.314

6.  Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.

Authors:  Yoshio Takemoto; Rafael J Ramirez; Kuljeet Kaur; Oscar Salvador-Montañés; Daniela Ponce-Balbuena; Roberto Ramos-Mondragón; Steven R Ennis; Guadalupe Guerrero-Serna; Omer Berenfeld; José Jalife
Journal:  J Am Coll Cardiol       Date:  2017-12-12       Impact factor: 24.094

7.  Gene expression effects of glucocorticoid and mineralocorticoid receptor agonists and antagonists on normal human skeletal muscle.

Authors:  Jessica A Chadwick; J Spencer Hauck; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Jill A Rafael-Fortney
Journal:  Physiol Genomics       Date:  2017-04-21       Impact factor: 3.107

Review 8.  Is there a new dawn for selective mineralocorticoid receptor antagonism?

Authors:  James M Luther
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-09       Impact factor: 2.894

Review 9.  Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.

Authors:  Nancy J Brown
Journal:  Nat Rev Nephrol       Date:  2013-06-18       Impact factor: 28.314

10.  Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats.

Authors:  G Youcef; A Olivier; N Nicot; A Muller; C Deng; C Labat; R Fay; R-M Rodriguez-Guéant; C Leroy; F Jaisser; F Zannad; P Lacolley; L Vallar; A Pizard
Journal:  Br J Pharmacol       Date:  2016-04-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.